Nuwellis (NASDAQ:NUWE) Stock, Quote.Headers.trade-ideas

Nuwellis

Nuwellis Inc is a medical device company. Its solutions includes Aquadex Smartflow System and RenalSense Clarity RMS. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Clarity RMS is a kidney monitoring system that continuously measures urine output and flows, automatically displaying real-time data to the medical staff.

movers image

News

Intraday Update

Markets

Movers

Trading Ideas

AVXL

BMRC

CERO

CGTX

COMM

COUR

CPTN

CTRI

IART

ITRG

LGVN

LIPO

LUXH

MESO

NIPG

NISN

NLSP

NOVA

NUWE

OPTT

PGHL

PHIO

PYPD

RNLX

SERV

TIVC

TNDM

TSLA

TWOU

VERO

VTVT

VTYX

YIBO

Why Bank of Marin Bancorp Shares Are Trading Lower? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Meet FLiRT And LB.1

Nuwellis shares are trading higher Monday after the company announced Friday that the first pediatric patient has been treated with the newly launched Quelimmune therapy in a commercial setting.

Why Nuwellis Stock Is Climbing

Crude-oil-4-logo

Eurozone

Commodities

AZTR

PIRS

SGMO

Crude Oil Gains 1%; AT&amp;T Shares Rise After Q2 Earnings

Nuwellis Inc

The United States will continue to keep a mid-range missile system in the Philippines, the decision comes despite demands from <a href="https://www.benzinga.com/news/24/07/39710570/us-has-better-global-image-than-china-survey-reveals">China for its removal</a>.
What Happened: The Typhon missile system, capable of launching missiles that can reach Chinese targets, was initially deployed for joint exercises earlier this year. However, it has remained in place, reported Reuters on Friday, citing sources familiar with the situation.
The Philippines, located near Taiwan, is a crucial part of the U.S. strategy in Asia. The missile system&#8217;s presence is seen as vital for supporting Taiwan in the event of a Chinese attack.
China and Russia have criticized the deployment, accusing the U.S. of escalating an arms race. China&#8217;s foreign ministry expressed significant concern over the decision to keep the system in place, stating it threatens regional security.
Philippine officials confirmed ongoing training with the missile system on the northern island of Luzon, near the South China Sea and Taiwan Strait, according to the report. They indicated no immediate plans to withdraw the system, even though joint exercises conclude this month.
A senior Philippine government official noted that the U.S. and the Philippines are testing the system&#8217;s feasibility for potential conflict scenarios. 
&#8220;It is up to the higher headquarters to decide on its stay, and most importantly the United States Army Pacific&nbsp;(USARPAC) because they own this, it is not our capability,&#8221; Philippines army spokesman, Colonel Louie Dema-ala said according to the report.
See Also: <a href="https://www.benzinga.com/news/24/09/40935722/spacex-ceo-elon-musk-says-anyone-can-go-to-mars-with-spacex-but-journey-would-be-like-a-long-sea-voy?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">SpaceX CEO Elon Musk Says Anyone Can Go To Mars With SpaceX But Journey Would Be Like A &#8216;Long Sea Voyage In Centuries Past&#8217;</a>
Why It Matters: The decision to retain the missile system in the Philippines comes amid a series of escalating tensions between the U.S. and China. 
Recently, President Joe Biden&#8216;s administration launched an investigation into a significant rise in <a href="https://www.benzinga.com/news/24/09/40896792/us-probes-surge-in-chinese-uranium-imports-amid-fears-of-russian-ban-evasion">enriched uranium imports from China</a>, suspecting it as a potential loophole for Russia to bypass a U.S. import ban. 
Additionally, key congressional panels have warned that the U.S. is lagging behind China in war preparedness. Lawmakers have <a href="https://www.benzinga.com/news/24/09/40936105/us-lagging-behind-china-in-war-preparedness-congressional-panels-warn">criticized outdated Pentagon procedures</a> and emphasized the need for faster technology transfers to allies.
Tensions in the South China Sea have also been on the rise. In June, a collision between Chinese and Philippine vessels near the Spratly Islands led to accusations of <a href="https://www.benzinga.com/news/24/06/39351335/us-ally-slams-chinas-claims-of-vessel-collision-as-deceptive-and-misleading-amid-rising-south-china">deceptive information from Beijing</a>. The Philippine military has previously condemned China&#8217;s actions as illegal within their exclusive economic zone.
Furthermore, a survey by the Pew Research Center revealed that the U.S. enjoys a significantly <a href="https://www.benzinga.com/news/24/07/39710570/us-has-better-global-image-than-china-survey-reveals">better global image</a> than China in numerous high- and middle-income countries. This perception plays a crucial role in the ongoing geopolitical rivalry between the two nations.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40931458/obama-era-economist-says-she-is-pleasantly-surprised-that-jd-vance-thinks-the-economy-is-too-strong?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Obama-Era Economist Says She Is &#8216;Pleasantly Surprised&#8217; That JD Vance Thinks The &#8216;Economy Is Too Strong For The Rate Cut&#8217;</a></li>
</ul>
Image Via Shutterstock 
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Kaustubh-Bagalkote" target="_blank" rel="noreferrer noopener">Kaustubh Bagalkote</a>

Global

US Keeps Missiles Vital For Defence Of Taiwan In Philippines Despite Beijing's Demands For Removal: Report

With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>FedEx Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) reported <a href="https://www.benzinga.com/news/earnings/24/09/40948046/fedex-q1-earnings-revenue-miss-eps-miss-lowered-guidance-challenging-quarter">weaker-than-expected results</a> for the first quarter of fiscal 2025 and lowered its full-year guidance. The company reported first-quarter revenue of $21.6 billion, missing analyst estimates of $21.955 billion, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. The company reported first-quarter adjusted earnings of $3.60 per share, missing analyst estimates of $4.80 per share. FedEx shares tumbled 11% to $267.25 in the after-hours trading session.</li>
<li>Wall Street expects VinFast Auto Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFS#NASDAQ">VFS</a>) to report a quarterly loss at 21 cents per share on revenue of $460.09 million before the opening bell. VinFast Auto shares rose 0.2% to $3.9665 in after-hours trading.</li>
<li>Chewy Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) announced a public offering by a selling stockholder and a concurrent share repurchase. Chewy shares fell 0.8% to $30.85 in the after-hours trading session.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>MillerKnoll, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLKN#NASDAQ">MLKN</a>) reported downbeat <a href="https://www.benzinga.com/news/earnings/24/09/40949071/millerknoll-stock-dips-after-q1-results-heres-why">first-quarter financial results</a> on Thursday. The company also said it sees second-quarter earnings of between 51 cents and 57 cents per share, versus the estimate of 61 cents, and second-quarter revenue in a range of $950 million to $990 million, versus the $948.12 million estimate. MillerKnoll shares declined 5.3% to $26.02 in the after-hours trading session.</li>
<li>Lennar Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) <a href="https://www.benzinga.com/news/earnings/24/09/40948948/homebuilder-lennar-reports-better-than-expected-q3-results-details">reported</a> better-than-expected financial results for the third quarter. The company said it sees fourth-quarter new orders in a range of 19,000 to 19,300 and deliveries between 22,500 and 23,000. The company expects the average sales price to be approximately $425,000. Lennar shares fell 2.4% to $187.75 in the after-hours trading session.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/40948972/coinbase-global-electronic-arts-and-2-other-stocks-executives-are-selling">Coinbase Global, Electronic Arts And 2 Other Stocks Executives Are Selling</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

Pre-Market Outlook

CHWY

MLKN

FedEx, Lennar And 3 Stocks To Watch Heading Into Friday

Palantir Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) co-founder, Joe Lonsdale, has expressed his support for Tesla and SpaceX CEO Elon Musk&#8217;s <a href="https://www.benzinga.com/news/23/04/31810229/elon-musk-bought-twitter-1-year-ago-a-look-back-at-whats-happened-since-and-what-could-be-next">acquisition of</a> Twitter, now rebranded as X.
What Happened: On Thursday, while appearing on CNBC&#8217;s Squawk Box, Lonsdale was asked about Musk&#8217;s sentiments toward his $44 billion purchase of Twitter. 
Lonsdale responded positively, suggesting that Musk&#8217;s acquisition was a crucial step for the preservation of the West.
&#8220;If Elon hadn&#8217;t bought Twitter, if he hadn&#8217;t done this, the entire West would be at 10x the threat,&#8221; he said and went on to underscore the significance of free speech in maintaining our civilization.
See Also: <a href="https://www.benzinga.com/news/23/05/32623067/how-to-take-the-perfect-moon-shot-using-an-iphone-14?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">How To Take The Perfect Moon Shot Using An iPhone 15</a>
When probed about the financial implications of the acquisition, Lonsdale acknowledged a decrease in revenue due to brands pulling their support.
However, he contended that this was a result of illegal coordination and attacks, which he deemed &#8220;probably illegal.&#8221;
he stated that while brands have the right to withdraw their support, behind-the-scenes coordination to damage a company is inappropriate.
Musk also shared the clip from this discussion on X and said, &#8220;Thanks Joe.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Thanks Joe <a href="https://t.co/swbYEjVnGW">https://t.co/swbYEjVnGW</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1836806074638434556?ref_src=twsrc%5Etfw">September 19, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Subscribe to the <a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a> to get all the latest tech developments delivered to your inbox.
Why It Matters: Musk&#8217;s acquisition of Twitter has been fraught with controversy. Just earlier this month, it was reported that X is expected to see a drastic <a href="https://www.benzinga.com/news/24/09/40762349/x-faces-major-advertiser-exodus-amid-string-of-elon-musk-controversies">reduction in advertising expenditure</a> in 2025, following a 26% decline in marketers' ad spending on the platform.
Last month, it was reported that since Musk&#8217;s acquisition, <a href="https://www.benzinga.com/startups/24/08/40533138/as-twitters-revenue-collapses-by-84-tesla-bulls-fear-elon-musk-will-liquidate-more-tesla-stock-bring">X&#8217;s revenue has plummeted by 84%</a>. This number also reportedly sparked fears among Tesla investors that Musk might sell more of his Tesla stock to fill the financial gap.
Previously, Meta Platforms Inc's president for global affairs, Nick Clegg, also criticized X for becoming a "tiny" platform for elites that <a href="https://www.benzinga.com/news/24/09/40852207/meta-exec-slams-elon-musks-x-as-tiny-platform-that-allows-anyone-say-anything">permits anyone to say anything</a>.
He also noted that individuals banned from Meta's platforms like Facebook and Instagram remain active on X and Telegram, and were involved in the far-right protests and riots in Britain last month.
Meanwhile, on Thursday morning, Palantir <a href="https://www.benzinga.com/news/24/09/40939510/palantir-stock-hits-52-week-highs-thursday-whats-going-on">shares made a new 52-week high</a>. This development came after the company got a new contract from the U.S. Army worth $99.8 million.
Check out more of Benzinga&#8217;s Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40914747/jpmorgan-ceo-jamie-dimon-thinks-social-media-platforms-like-tiktok-and-facebook-are-a-total-stupid-w?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">JPMorgan CEO Jamie Dimon Thinks Social Media Platforms Like TikTok And Facebook Are &#8216;A Total Stupid Waste Of Time&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a> and was reviewed and published by Benzinga editors.

Social Media

Tech

PLTR

Palantir Co-Founder Joe Lonsdale Backs Elon Musk's Twitter Acquisition, Saying If He Had Not Bought It Then 'The Entire West Would Be At 10x The Threat'

<ul>
<li>Kineta will be trading under the symbol &quot;KANT&quot; on OTC Pink</li>
<li>Kineta will continue to pursue strategic alternatives as previously announced</li>
<li>TuHURA Biosciences has an exclusivity right and a right of first offer for Kineta&#39;s KVA12123 program</li>
<li>The ongoing KVA12123 Phase 1 study is open for new patient enrollment and following those patients previously enrolled.</li>
</ul>

Reported Earlier, Kineta Transitions From Nasdaq To OTC Markets, Continues Focus On Strategic Alternatives

Approval based on compelling safety and efficacy from the Phase 3 MARIPOSA-2 study, marking&nbsp;the third new indication for RYBREVANT&reg;&nbsp;this year, with four indications overall

Johnson & Johnson Announces FDA Approval Of RYBREVANT Plus Chemotherapy As The First Targeted Therapy To Halve Disease Progression Risk In Second-Line EGFR-Mutated Lung Cancer

Macro Economic Events

Econ #s

Economics

Germany Producer Price Index (MoM) For August 0.2% Vs. 0.0% Est.; 0.2% Prior

U.K. Retail Sales (YoY) For August 2.5% Vs. 1.4% Est.; 1.5% (Revised) Prior

U.K. Retail Sales (MoM) For August 1.0% Vs. 0.3% Est.; 0.7% (Revised) Prior

U.K. Core Retail Sales (YoY) For August 2.3% Vs. 1.1% Est.; 1.4% Prior

U.K. Core Retail Sales (MoM) For August 1.1% Vs. 0.5% Est.; 1.0% (Revised) Prior

TRIN

Reported Earlier, Trinity Capital Expands Credit Facility To $510M With $70M Boost From New Lenders

Ascendis estimates the net proceeds from the offering will be approximately&nbsp;$281.3 million&nbsp;(assuming no exercise of the underwriters&#39; option to purchase additional ADSs), after deducting the underwriting commissions and estimated offering expenses. Ascendis intends to use the net proceeds of the offering to support the commercial preparations, launch and commercial activities, clinical development and regulatory approvals for its products and product candidates, and for working capital and general corporate purposes.

ASND

Reported Earlier, Ascendis Pharma Prices $281.3M Public Offering Of 2M ADSs At $150/ADS

Leveraging NVIDIA accelerated computing and offering personalized drinks, Scorpion is expected to save costs, generate revenue, and provide an unforgettable customer experience

Reported Earlier, Richtech Robotics Launches Scorpion, An AI-Driven Single-Arm Beverage Service Robot, And Secures 500-Unit Distribution Deal Over Five Years

Agreement designed to foster collaboration and usage of quantum computing solutions for optimization and AI applications

QBTS

Reported Earlier, D-Wave And Staque Join Forces To Accelerate Annealing Quantum Computing Adoption Across The Middle East

The gross proceeds from the sale of the shares by the Selling Stockholders will be approximately $2.2 billion. Diamondback will not receive any proceeds from the sale of the shares by the Selling Stockholders. The Secondary Offering is expected to close on September 23, 2024, subject to customary closing conditions.
In addition, Diamondback has agreed to purchase from the underwriters 2,000,000 shares of common stock that are the subject of the Secondary Offering at a price per share equal to the price per share to be paid by the underwriters to the Selling Stockholders (the &quot;Share Repurchase&quot;) under Diamondback&#39;s existing share repurchase program. Diamondback plans to fund the Share Repurchase from existing cash on hand. The underwriters will not receive any compensation for the shares being repurchased by Diamondback in the Share Repurchase.

FANG

Reported Earlier, Diamondback Energy Prices Upsized $2.2B Secondary Common Stock Offering Of 12.77M Shares

YouTube, a subsidiary of&nbsp;Alphabet Inc.&#8217;s&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google, has announced the implementation of &#8220;Pause ads,&#8221; a feature that <a href="https://www.benzinga.com/news/23/11/35613857/youtubes-war-against-ad-blockers-leads-to-record-uninstalls-but-users-are-fighting-back">displays advertisements</a> even when a video is paused.
What Happened: On Thursday, YouTube confirmed the broad rollout of &#8220;Pause ads&#8221; to all advertisers. Now, when a user pauses a video, an ad will appear&nbsp;on the side of the&nbsp;screen, <a href="https://edition.cnn.com/2024/09/19/business/youtube-ads-paused-screen/index.html">reported</a> CNN.
The new feature is intended to be &#8220;seamless for viewers&#8221; and offers an opportunity for&nbsp;them to learn more about&nbsp;a brand, a Google spokesperson told the report.
The update is seen as beneficial&nbsp;for the entire YouTube ecosystem&nbsp;and is part of the modern Connected TV (CTV) ads experience.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/09/40932378/elon-musks-x-manages-to-dodge-brazil-ban-with-software-update-court-wants-an-explanation?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk&#8217;s X Manages To Dodge Brazil Ban With Software Update, Court Wants An Explanation</a>
Despite YouTube&#8217;s assertion that&nbsp;the update creates a less&nbsp;interruptive viewing experience, social media users have voiced their annoyance over the new, unavoidable ads.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Seriously <a href="https://twitter.com/YouTube?ref_src=twsrc%5Etfw">@YouTube</a>? You&#39;re putting up ads when you pause a video now? I am about to install a computer in place of the fire stick so I can have an ad blocker&#8230; Your ads are getting ridiculous. <a href="https://t.co/OT4JMduGTU">pic.twitter.com/OT4JMduGTU</a>
&mdash; RoÆther (@Roaether) <a href="https://twitter.com/Roaether/status/1832186161743216724?ref_src=twsrc%5Etfw">September 6, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">nice one thing i hate when i pause a youtube video is the silence <a href="https://t.co/86sNagJ9Y4">https://t.co/86sNagJ9Y4</a>
&mdash; Keefler (@Keefler_Elf) <a href="https://twitter.com/Keefler_Elf/status/1836947769317020159?ref_src=twsrc%5Etfw">September 20, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/YouTube?ref_src=twsrc%5Etfw">@YouTube</a> Playing ads when pausing a video is an absolute trash idea. Stop trying these atrocious implementations to try to strongarm users into your subscription service. When I pause a video I want to disconnect not have to also wait to mute/pause/skip and ad.
&mdash; Cannoli Senpai (@CannoliSenpai) <a href="https://twitter.com/CannoliSenpai/status/1836956020226040198?ref_src=twsrc%5Etfw">September 20, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Users can still avoid ads&nbsp;with a YouTube Premium subscription, which costs&nbsp;$13.99 a month for an&nbsp;individual.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: The introduction of &#8216;Pause ads&#8217; comes amid growing user frustration over the increasing number of ads on YouTube. Last year, Elon Musk agreed with millions of users worldwide that <a href="https://www.benzinga.com/news/23/10/35483941/elon-musk-agrees-with-millions-of-users-worldwide-youtube-ads-are-getting-out-of-control">YouTube ads were &#8220;getting out of control.&#8221;</a>
In May this year, some YouTube users with ad blockers installed reported that their videos were skipping to the end, a phenomenon that was speculated to be a strategy by <a href="https://www.benzinga.com/news/24/05/39054233/youtube-videos-reportedly-skipping-to-the-end-for-ad-block-users-bug-or-strategy">YouTube to counter ad blockers</a>.
YouTube has also been experimenting with new ways to prevent rampant ad-blocking on the platform, including <a href="https://www.benzinga.com/general/entertainment/24/06/39438445/youtube-steps-up-ad-blocker-crackdown-is-it-making-a-difference">server-side ad injection</a>.
Image via Shutterstock
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40892284/oracles-larry-ellison-predicts-police-officers-will-be-supervised-at-all-times-and-citizens-will-be?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Oracle&#8217;s Larry Ellison Predicts Police Officers Will Be Supervised &#8216;At All Times&#8217; And Citizens Will Be On Their Best Behavior Thanks To Constant AI-Powered Surveillance</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.

Media

GOOG

GOOGL

There Is No Escaping YouTube Ads Even After Hitting The Pause Button — Disgruntled Users Cry Foul: 'An Absolute Trash Idea'

BBJP

WisdomTree Trust Japan Total Dividend Fund

Reported Earlier, Japan Interest Rate Decision Unchanged At 0.25%

Reported Earlier, People's Bank of China Loan Prime Rate Unchanged At 3.35%

Reported Earlier, China Loan Prime Rate 5Y For September Unchanged At 3.85%

Reported Earlier, Japan National Consumer Price Index (MoM) For August 0.5% Vs. 0.2% Prior

An announcement from Nuwellis (NUWE) is now available. Nuwellis, Inc. has announced a financial move to boost its capital, having entered into agre...

Nuwellis Announces Equity Offering to Strengthen Finances

Catalyst Watch: Tech blitz with Apple, Amazon, Microsoft, and Meta on tap for earnings

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning!



Moving stocks this morning are clinical trial updates, an acquisition deal and a public offering.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Planet Image (NASDAQ:<a href="https://investorplace.com/stock-quotes/yibo-stock-quote/">YIBO</a>) stock is rocketing more than 79% alongside heavy pre-market trading.</li>



<li>Lipella Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/lipo-stock-quote/">LIPO</a>) shares are soaring over 58% after <a href="https://www.stocktitan.net/news/LIPO/lipella-pharmaceuticals-initiates-phase-2a-trial-for-lp-310-in-oral-kdvluw7gmnv7.html">initiating a Phase 2a clinical trial</a>.</li>



<li>Cognition Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cgtx-stock-quote/">CGTX</a>) stock is surging more than 44% with <a href="https://www.nasdaq.com/press-release/cognition-therapeutics-proof-concept-phase-2-shine-trial-demonstrates-consistent">positive Phase 2 study results</a>.</li>



<li>Tivic Health Systems (NASDAQ:<a href="https://investorplace.com/stock-quotes/tivc-stock-quote/">TIVC</a>) shares are gaining over 32% following a <a href="https://www.nasdaq.com/press-release/bestgrowthstockscom-issues-comprehensive-analysis-tivic-health-systems-potential">breakdown of its potential catalysts</a>.</li>



<li>Longeveron (NASDAQ:<a href="https://investorplace.com/stock-quotes/lgvn-stock-quote/">LGVN</a>) stock is increasing more than 22% with the release of <a href="https://www.nasdaq.com/press-release/longeveronr-presents-study-results-clear-mind-phase-2a-clinical-trial-lomecel-btm">Phase 2a study results</a>.</li>



<li>Pineapple Financial (NYSEMKT:<a href="https://investorplace.com/stock-quotes/papl-stock-quote/">PAPL</a>) shares are rising 22% without any clear news this morning.</li>



<li>Cepton (NASDAQ:<a href="https://investorplace.com/stock-quotes/cptn-stock-quote/">CPTN</a>) stock is climbing over 19% on <a href="https://www.stocktitan.net/news/CPTN/cepton-signs-definitive-agreement-to-be-acquired-by-7cwu0k4o8p93.html">an acquisition agreement</a>.</li>



<li>Ambipar Emergency (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ambi-stock-quote/">AMBI</a>) shares are jumping more than 18% this morning.</li>



<li>BurgerFi (NASDAQ:<a href="https://investorplace.com/stock-quotes/bfi-stock-quote/">BFI</a>) stock is heading over 16% higher as it <a href="https://investorplace.com/2024/07/why-is-burgerfi-international-bfi-stock-up-71-today/">continues a recent rally</a>.</li>



<li>Vaccinex (NASDAQ:<a href="https://investorplace.com/stock-quotes/vcnx-stock-quote/">VCNX</a>) shares are up more than 15% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>vTv Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/vtvt-stock-quote/">VTVT</a>) stock is plummeting over 44% after announcing the Food and Drug Administration&nbsp;(FDA) <a href="https://www.nasdaq.com/press-release/vtv-therapeutics-announces-cadisegliatin-program-type-1-diabetes-placed-clinical-hold">placed a clinical hold</a> on one of its trials.</li>



<li>CERo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cero-stock-quote/">CERO</a>) shares are diving more than 33% despite a lack of news this morning.</li>



<li>Treasure Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/tgl-stock-quote/">TGL</a>) stock is tumbling over 25% on Monday morning.</li>



<li>LuxUrban Hotels (NASDAQ:<a href="https://investorplace.com/stock-quotes/luxh-stock-quote/">LUXH</a>) shares are taking a more than 17% beating after <a href="https://www.globenewswire.com/news-release/2024/07/27/2919920/0/en/LuxUrban-Hotels-Announces-Pricing-of-Public-Offering-of-Securities.html">pricing a public offering</a>.</li>



<li>Invo Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/invo-stock-quote/">INVO</a>) stock is dropping over 11% without any clear news to report.</li>



<li>Phio Pharmaceuticals&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/phio-stock-quote/">PHIO</a>) shares are sliding more than 11% this morning.</li>



<li>Notable Labs (NASDAQ:<a href="https://investorplace.com/stock-quotes/ntbl-stock-quote/">NTBL</a>) stock is decreasing over 10% on Monday morning.</li>



<li>Regencell Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/rgc-stock-quote/">RGC</a>) shares are falling more than 9% after a Friday rally.</li>



<li>Carbon Revolution (NASDAQ:<a href="https://investorplace.com/stock-quotes/crev-stock-quote/">CREV</a>) stock is slipping over 9% after jumping Friday <a href="https://finance.yahoo.com/news/carbon-revolution-supplies-carbon-fiber-011000695.html">on a wheels deal</a>.</li>



<li>Nuwellis (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuwe-stock-quote/">NUWE</a>) shares close out our pre-market stock movers down more than 9%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/07/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-july-29th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Nuwellis Q2 Earnings Preview

Nuwellis GAAP EPS of -$18.85 misses by $10.61, revenue of $2.19M beats by $0.19M

Nuwellis, Inc. (NUWE) Q2 2024 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Nuwellis (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuwe-stock-quote/">NUWE</a>) just reported results for the second quarter of 2024.<ul><li>Nuwellis reported earnings per share of -$4.68. This was above the analyst estimate for EPS of -$8.24.</li><li>The company reported revenue of $2.19 million.</li><li>This was 9.70% better than the analyst estimate for revenue of $2.00 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/nuwe-stock-earnings-nuwellis-for-q2-of-2024/">NUWE Stock Earnings: Nuwellis Beats EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

NUWE Stock Earnings: Nuwellis Beats EPS, Beats Revenue for Q2 2024

Maxim Group analyst Anthony Vendetti maintained a Hold rating on Nuwellis (NUWE – Research Report) yesterday. The company's shares closed yesterday...

Maxim Group Keeps Their Hold Rating on Nuwellis (NUWE)

Nuwellis to sell 496,901 shares at $1.845 in registered direct offering

Nuwellis (NUWE) has issued an update. Nuwellis, Inc. has launched a financial venture, selling over 483,000 shares at $1.8450 each, alongside warra...

Nuwellis Secures Funds Through Shares and Warrants Offering

AAPL

ABVE

ADBE

ALEC

AMBI

AMZN

BIRD

CREV

CRWD

DASH

DELL

DKNG

EBAY

ETSY

FEIM

HLVX

INTC

INVO

LMND

MSFT

NTBL

NUWEW

NVDA

PAPL

QCOM

RBLX

SBUX

SNBR

SPGI

TWLO

VCNX

VSTO

WELL

XPEV

ZAPP

Health Care

Press Releases

New Evidence on Aquadex Ultrafiltration Therapy to be Presented at HFSA 2024 Conference

SeaStar Medical Ships First QUELIMMUNE Product Order to U.S. Distribution Partner

General

Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children's

Nuwellis, Inc. To Report Second Quarter 2024 Financial Results on August 13, 2024

Nuwellis Announces Pricing of $2.0 Million Offering Priced At-The-Market Under Nasdaq Rules

Nuwellis Announces First Pediatric Patient Treated in a Commercial Setting with SeaStar Medical's QUELIMMUNE™ Therapy at Cincinnati Children's

Nasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq Stock Market, Subject to Conditions

Nuwellis, Inc. Announces Second Quarter 2024 Financial Results

Nuwellis Announces Pricing of $916,000 Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

New Study Published in Current Problems in Cardiology Highlights Statistically Significant Reduction in Heart Failure Readmissions at 60 days when using the Aquadex Ultrafiltration Therapy

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Nuwellis

Nuwellis (NUWE) Forecast

Nuwellis (NASDAQ:NUWE) Stock, Quote.Headers.trade-ideas